26-valent Pneumococcal Conjugate Vaccine

Pneumococcal conjugate vaccine, 26-valent · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 26-valent Pneumococcal Conjugate Vaccine, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine [Phase 1, Phase 2]